MENU
RAPT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
RAPT Therapeutics (RAPT) Ownership - Who owns RAPT Therapeutics?
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company... Show more
Profile
Industry
N/A
Address
561 Eccles Avenue
Phone
+1 650 489-9000
Employees
131
Web
https://www.rapt.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
177.29M
P/E Ratio
N/A
Total Cash
168.95M
Projected Growth
N/A
Total Debt
3.16M
Revenue
N/A
Risk (Beta)
-0.59
Dividend Yield
N/A
Total Cash/Share
10.22
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
RAPT
Capitalization
177M
P/E Ratio
N/A
Risk (Beta)
-0.59
Dividend Yield
N/A
Total Cash
169M
Total Cash/Share
10.22
Total Debt
3.16M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
164M
P/B Ratio
1.08
Cash Flow
N/A
Earnings
-14.8
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
13K
Current Ratio
13.25
Current Revenue Per Employee
10068.18
Dividends Per Share - Security
N/A
EBITDA
-111.99M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-69.69
Shares Held By Institutions
138M
Shares Outstanding - Current
16.5M
Total Liabilities
14M
Total Volume MTD
N/A
Value
-1
Gain YTD
-15.190
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information
General Information
a clinical stage immunology-based biopharmaceutical company
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
561 Eccles Avenue
Phone
+1 650 489-9000
Employees
131
Web
https://www.rapt.com